Skip to main content
. 2020 Mar 2;60(7):903–914. doi: 10.1002/jcph.1590

Figure 4.

Figure 4

Impact of covariates on average concentrations of ontamalimab at week 12 for the 75‐mg Q4W regimen. Note: The reference subject was a 70‐kg patient with UC or CD, with albumin and CRP levels of 39 g/L and 0.837 mg/dL, respectively. CD, Crohn's disease; CI, confidence interval; CRP, C‐reactive protein; Q4W, every 4 weeks; UC, ulcerative colitis.